MACROGENICS, INC. Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31)
MACROGENICS, INC. (MGNX) reported Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) of $0 for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-05.
Discontinued › Notes
us-gaap:UndistributedEarningsAllocatedToParticipatingSecurities · last filed 2014-08-05
- MACROGENICS, INC. undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2014-06-30 was $0.00.
- MACROGENICS, INC. undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2013-09-30 was $6.43M, a 147.44% increase year-over-year.
- MACROGENICS, INC. undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2013-06-30 was $0.00.
- MACROGENICS, INC. undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2012-12-31 was -$2.10M.
- MACROGENICS, INC. undistributed earnings allocated to participating securities (deprecated 2014-01-31) for fiscal 2012 was $8.36M, a 24.48% increase from fiscal 2011.
- MACROGENICS, INC. undistributed earnings allocated to participating securities (deprecated 2014-01-31) for fiscal 2011 was $6.72M.
| Period end | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 3 month | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 6 month | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 9 month | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|
| 2014-06-30 | $0.00 10-Q · filed 2014-08-05 | $0.00 10-Q · filed 2014-08-05 | ||
| 2013-09-30 | $6.43M 10-Q · filed 2013-11-12 | $6.43M derived: sum of 2 quarters · filed 2014-08-05 | $2.94M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-05 | $0.00 10-Q · filed 2014-08-05 | ||
| 2012-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $495.69K derived: sum of 2 quarters · filed 2014-03-20 | $8.36M 10-K · filed 2014-03-20 | |
| 2012-09-30 | $2.60M 10-Q · filed 2013-11-12 | $10.47M 10-Q · filed 2013-11-12 | ||
| 2011-12-31 | $6.72M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |